2021-2022 Opioid Education for Utah Licensed Practitioners

This course satisfies the Utah Division of Occupational and Professional Licensing (DOPL) mandate which states that beginning with the licensing period that begins after January 1, 2014, as a condition precedent for license renewal, each controlled substance prescriber shall complete at least 3.5 continuing education hours per licensing period. The 3 hours of the core curriculum includes educational content covering the following:

  1. the scope of the controlled substance abuse problem in Utah and the nation,
  2. all elements of the FDA Blueprint for Prescriber Education under the FDA’s Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy, as published July 9, 2012, or as it may be subsequently revised,
  3. the national and Utah-specific resources available to prescribers to assist in appropriate controlled substance and opioid prescribing,
  4. patient record documentation for controlled substance and opioid prescribing, and
  5. office policies, procedures, and implementation

Learners will need to pick at a minimum an additional half-hour of electives to satisfy the 3.5-hour requirement. Learners have the opportunity to earn a maximum of 8 hours of continuing education if all electives are taken.

This current course satisfies at least 3.5 hours of continuing education for controlled substance prescribers, except dentists who shall complete at least 2 hours to satisfy the DOPL requirements. This controlled substance prescribing class satisfies the division’s requirements for the continuing education required for the renewal of the controlled substance prescriber’s respective license type, is delivered by an accredited continuing education provider recognized by the division as offering continuing education appropriate for the controlled substance prescriber’s respective license type, and include a post-course knowledge assessment.

In addition, an M.D. or D.O. completing continuing professional education hours will complete those hours in classes that qualify for the American Medical Association Physician’s Recognition Award Category 1 credit. All others (non-M.D. or D.O.s) could also seek continuing education credits in accordance with your organizations’ requirements. We are also offering maintenance of certificate Part II credits for the following boards: American Board of Otolaryngology Head and Neck Surgery, American Board of Ophthalmology, American Board of Pathology, American Board of Internal Medicine, American Board of Pediatrics, and American Board of Anesthesiology. Please ensure you provide the necessary credentials upon registration to receive these credits.

Please note: A controlled substance prescriber who, on or after July 1, 2017, obtains a waiver to treat opioid dependency with narcotic medications, in accordance with the Drug Addiction Treatment Act of 2000, 21 U.S.C. Sec. 823 et seq., may use the waiver to satisfy the 3.5 hours of the continuing education requirement for two consecutive licensing periods. Therefore this course is not intended for those prescribers

Target Audience

Anyone in Utah licensed to prescribe opioids (physicians, APRNs, PAs, dentists, residents, and fellows)  

Learning Objectives

  • Improve our understanding of appropriate opioid prescribing and
  • Decrease opioid dependence, misuse, and overdose

Additional Information

Partner: 
Substance Education Institute
The University Of Utah School Of Medicine
Course summary
Available credit: 
  • 7.50 MOC
  • 8.00 AMA PRA Category 1 Credit™
Course opens: 
11/10/2021
Course expires: 
12/23/2023
Cost:
$49.95
Rating: 
0

Designed by University of Utah Faculty:

PAULA COOK, MD

NICHOLAS COX, PharmaD

KATHERINE FORTENBERRY, PhD

CAMILLE FUNG, MD 

KAREN GUNNING, PharmaD

SCOTT JUNKINS, MD 

DOMINIC MOORE, MD

DANIEL ODELL, MD

JENNIFER PLUMB, MD

MARCELA SMID, MD

ROBERT ANDRES, MD

 

Disclosure:
Neither the speaker(s), planner(s), nor anyone in control of content for this enduring activity have any financial relationship with commercial products or services discussed today the exception of Marcela Smid, who is a scientific advisor for Gilead Science Inc, and Scott Junkins, who is a one-time consultant/Advisory Board for Roche. All relevant financial relationships have been mitigated.

Accreditation:
The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit:
The University of Utah School of Medicine designates this enduring activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Speaker and Planning Committee Disclosure Summary:
The University of Utah School of Medicine Continuing Medical Education Office (UUCME) meets ACCME Standards for Integrity and Independence expectations regarding the identification and mitigation of relevant financial relationships with ACCME-defined ineligible companies. Everyone in control of content, including all speakers and planners, must disclose financial relationships in any amount within the past 24 months and any relevant financial relationships must be mitigated prior to the activity start.

MOC Part II
Need all Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 08.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program; and
  • 08.00MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; and
  • 08.00 MOC points in the American Board of Otolaryngology Head and Neck Surgery Continuing Certification Lifelong Learning and Self-Assessment (ABOHNS) Maintenance of Certification (MOC part II) and enables the participant to earn their required annual part II self‐ assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). ; and
  • 08.00 MOC Points in the American Board of Ophthalmology Lifelong Learning and Self-Assessment (ABO) and enables the learner to satisfy the Lifelong Learning, Self‐Assessment, Improvement in Medical Practice and/or Patient Safety requirements for the American Board of Ophthalmology’s Maintenance of Certification program.; and
  • 08.00 MOC Points in the American Board of Pathology Lifelong Learning (ABPath) and enables the participant to earn up to 1.0 Lifelong Learning (CME) credit in the American Board of Pathology (ABPath) Continuing Certification program.; and
  • 08.00 MOC Points in the American Board of Anesthesiology (ABA) Successful completion of this CME activity enables the participant to earn up to 8.00 MOCA 2.0® points in the American Board of Anesthesiology® Maintenance of Certification in Anesthesiology Program®. Maintenance of Certification in Anesthesiology Program® and MOCA® are registered certification marks of the American Board of Anesthesiology®. MOCA 2.0® is a trademark of the American Board of Anesthesiology®

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM, ABP, ABA, ABOHNS, ABO and ABPath MOC Part II credits

Available Credit

  • 7.50 MOC
  • 8.00 AMA PRA Category 1 Credit™

Price

Cost:
$49.95
Please login or register to take this course.

This course is offered through The University Of Utah School Of Medicine.

To take this course you will be redirected to The University Of Utah School Of Medicine's website. You must login or create an account with The University Of Utah School Of Medicine in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!

Topics